Thrombosis

Latest Features

Vascular Medicine Questions Remain Regarding VTE Recurrence in Older Adults

Questions Remain Regarding VTE Recurrence in Older Adults

Venous thromboembolism recurrence risk may not be any higher in older patients than in younger patients.

Latest News

Rivaroxaban in VTE: Lower Clinical Event Costs, But Higher Healthcare Costs

Rivaroxaban in VTE: Lower Clinical Event Costs, But Higher Healthcare Costs

Rivaroxaban was associated with lower clinical event costs but higher total healthcare costs compared with aspirin in patients with venous thromboembolism.

Baseline Thrombocytopenia Associated With Mortality Risk in VTE

Baseline Thrombocytopenia Associated With Mortality Risk in VTE

Patients with VTE with moderate to severe thrombocytopenia at baseline were associated with increased risk for major bleeding events and all-cause mortality.

VTE Increases Risk for Chronic Thromboembolic Pulmonary Hypertension

VTE Increases Risk for Chronic Thromboembolic Pulmonary Hypertension

A number of risk factors were associated with chronic thromboembolic pulmonary hypertension, including, age >70 years, female gender, and pulmonary embolism at first venous thromboembolism.

Pulmonary Embolism AEs Increase With DOAC Doses Against Manufacturer Recs

Pulmonary Embolism AEs Increase With DOAC Doses Against Manufacturer Recs

Patients treated for acute pulmonary embolism with direct oral anticoagulants at doses against manufacturer recommendations had a higher rate of major bleeding events.

FDA Approves Epoetin Alfa Biosimilar Retacrit

FDA Approves Epoetin Alfa Biosimilar Retacrit

The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and its reference product.

First Generic Alternative for Mephyton Now Available

First Generic Alternative for Mephyton Now Available

Amneal's generic product is available in a 5mg strength tablet supplied in 100-count bottles.

Oral Anticoagulant Effective in Recurrent VTE Prevention in Cancer Patients

Oral Anticoagulant Effective in Recurrent VTE Prevention in Cancer Patients

At the end of 6 months, the rate of VTE recurrence was 4% among rivaroxaban patients vs 11% in the dalteparin arm (hazard ratio [HR] 0.43, 95% CI: 0.19 to 0.99).

Veno-Arterial Extracorporeal Membrane Oxygenation Improves Survival in Pulmonary Embolism

Veno-Arterial Extracorporeal Membrane Oxygenation Improves Survival in Pulmonary Embolism

A protocolized study including initiation of VA-ECMO may reduce mortality in patients with massive PE.

Independent Predictors of VTE Identified in Systemic Sclerosis

Independent Predictors of VTE Identified in Systemic Sclerosis

Researchers evaluated the prevalence, risk factors, and effect of venous thromboembolism on survival in systemic sclerosis.

Deep Venous Thrombosis Ultrasound Protocol Recommendations

Deep Venous Thrombosis Ultrasound Protocol Recommendations

The Society of Radiologists in Ultrasound has endorsed recommendations regarding ultrasound imaging test protocols for patients with suspected deep venous thrombosis.

Sign Up for Free e-Newsletters